Search results :

Ofatumumab

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: L01XC10

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2
Neutropenia Neutropenia 14% - 56% x x
Pneumonia Pneumonia 14% - 25% x x
Lymphopenia Lymphopenia 7% - 20% x x
Body temperature increased Body temperature increased 3% - 25% x x
Anaemia Anaemia 5% - 17% x x
Cough Cough 0% - 19% x x
Dyspnoea Dyspnoea 2% - 19% x x
Diarrhoea Diarrhoea 0% - 19% x x
Sepsis Sepsis 8% - 10% x x
Dermatitis Rash 1% - 17% x x
Rash Rash 1% - 17% x x
Asthenia Fatigue 0% - 15% x x
Asthenia 0% - 5% x
Fatigue Fatigue 0% - 15% x x
Bronchitis Bronchitis 1% - 19% x
Nausea Nausea 0% - 12% x x
Back pain Back pain 1% - 12% x x
Oedema peripheral Oedema peripheral 1% - 9% x
Herpes zoster Herpes zoster 1% - 7% x
Nasopharyngitis Nasopharyngitis 0% - 8% x
Chills Chills 0% - 10% x x
Rigors x
Tachycardia Tachycardia 1% - 7% x x
Insomnia Insomnia 0% - 10% x
Leukopenia Leukopenia 1% - 28% x x
Hyperhidrosis Hyperhidrosis 0% - 5% x x
Hypertension Hypertension 0% - 8% x x
Sinusitis Sinusitis 2% - 5% x
Urticaria Urticaria 0% - 8% x x
Herpes simplex Herpes simplex 1% - 4% x
Lower respiratory tract infection Lower respiratory tract infection 1% - 3% x x
Arthralgia Arthralgia 0% - 3% x
Musculoskeletal discomfort Arthralgia 0% - 3% x
Headache Headache 0% - 7% x
Hypotension Hypotension 0% - 5% x x
Muscle spasms Muscle spasms 0% - 5% x
Upper respiratory tract infection Upper respiratory tract infection 0% - 11% x x
Abdominal pain upper Abdominal pain upper 0% - 3% x
Cardiac arrest Cardiac arrest postmarketing x
Erythema multiforme Stevens-Johnson syndrome postmarketing x
Stevens-Johnson syndrome Stevens-Johnson syndrome postmarketing x
Porphyria non-acute Porphyria cutanea tarda postmarketing x
Agranulocytosis Agranulocytosis x x
Anaphylactic shock Anaphylactic shock x
Anaphylactoid reaction x
Bacteraemia Bacteraemia x
Coagulopathy Coagulopathy x
Bronchospasm Bronchospasm x
Bronchopneumonia Bronchopneumonia x
Infection Infection x x
Connective tissue disorder Connective tissue disorder x
Pancytopenia Cytopenia x
Flushing Flushing x x
Gastrointestinal disorder Gastrointestinal disorder x
Cardiac disorder Cardiac disorder x
Hepatitis B Hepatitis B x x
Herpes virus infection Herpes NOS x
Herpes virus infection x x
Genital herpes Genital herpes x
Hypersensitivity Hypersensitivity x
Immune system disorder Immune system disorder x
Progressive multifocal leukoencephalopathy Progressive multifocal leukoencephalopathy x
Mediastinal disorder Mediastinal disorder x
Fungal infection Fungal infection x x
Nasal congestion Nasal congestion x
Pain Pain x
Lobar pneumonia Lobar pneumonia x
Pruritus Pruritus x x
Septic shock Septic shock x x
Thrombocytopenia Thrombocytopenia x
Tumour lysis syndrome Tumour lysis syndrome x x
Urinary tract infection Urinary tract infection x
Angiopathy Angiopathy x
Viral infection Viral infection x
Malnutrition Malnutrition x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Rash macular Rash macular x
Rash vesicular Rash vesicular x
Small intestinal obstruction Small intestinal obstruction x
Chest pain Chest discomfort x
Chest discomfort Chest discomfort x
Aplasia Aplasia x
Anaphylactoid reaction Anaphylactoid reaction x
Oral herpes Oral herpes x
Febrile neutropenia Febrile neutropenia x
Infestation Infestation NOS x
Laryngeal pain Pharyngolaryngeal pain x
Lung infection Lung infection x
Neutropenic sepsis Neutropenic sepsis x x
Cytokine release syndrome Cytokine release syndrome x
Death Death x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

ofatumumab / ofatumumab

Side effects:56
Source:EMA

OFATUMUMAB

Side effects:61
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label